Ge Healthcare Technologies revenue was $19.56B for the trailing 12 months ending Sep 30, 2024, with 8.9% growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $4.9B, up 0.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, GEHC annual revenue was $19.6B, with 6.6% growth year-over-year.
GEHC past revenue growth
How has GEHC's revenue growth performed historically?
On Invalid Date, Ge Healthcare Technologies (NASDAQ: GEHC) reported Q3 2024 revenue of $4.86 billion up 0.85% year over year. In the same quarter last year, Ge Healthcare Technologies's revenue was $4.82 billion.
What was Ge Healthcare Technologies's revenue in 2023?
Ge Healthcare Technologies's annual revenue for the twelve months ending Dec 31, 2023 was $19.55 billion, a 6.6% increase year over year.
How much does Ge Healthcare Technologies make in a day?
Based on Ge Healthcare Technologies annual revenue for the past four years, GEHC makes an average of $49,754,794.52 per day.
What was Ge Healthcare Technologies's annual revenue growth in the past year?
As of Q4 2024, Ge Healthcare Technologies's revenue has grown 1.42% year over year. This is 8.41 percentage points lower than the US Health Information Services industry revenue growth rate of 9.83%. Ge Healthcare Technologies's revenue in the past year totaled $19.56 billion.
How much does Ge Healthcare Technologies make in a year?
Ge Healthcare Technologies's revenue by year for the past four years is:
Ge Healthcare Technologies's revenue for the twelve months ending Dec 31, 2023 was $19.55 billion, a 6.6% increase year over year.
Ge Healthcare Technologies's annual revenue for Dec 31, 2022 was $18.34 billion, a 4.3% increase from 2021.
Ge Healthcare Technologies's annual revenue for 2021 was $17.59 billion, a 2.45% increase from 2020.
Ge Healthcare Technologies's annual revenue for 2020 was $17.16 billion, a 3.19% increase from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.